Travere Therapeutics, Inc. (TVTX) Social Stream
TRAVERE THERAPEUTICS INC (TVTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering TRAVERE THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-15 | 7 | $45 | $20 | $37 | $7.64 | 384.29% |
| 2021-12-16 | 7 | $45 | $20 | $37.833 | $7.64 | 395.2% |
| 2022-01-10 | 7 | $45 | $25 | $38.666 | $7.64 | 406.1% |
| 2022-01-25 | 7 | $45 | $27 | $39 | $7.64 | 410.47% |
| 2022-02-25 | 7 | $45 | $27 | $37 | $7.64 | 384.29% |
| 2022-02-28 | 6 | $45 | $27 | $40.285 | $7.64 | 427.29% |
| 2022-03-10 | 5 | $45 | $27 | $39.5 | $7.64 | 417.02% |
| 2022-04-20 | 8 | $45 | $27 | $39.857 | $7.64 | 421.69% |
| 2022-04-25 | 8 | $45 | $27 | $40.714 | $7.64 | 432.91% |
| 2022-04-28 | 8 | $45 | $24 | $40.875 | $7.64 | 435.01% |
| 2022-05-06 | 8 | $45 | $24 | $40.5 | $7.64 | 430.1% |
| 2022-05-16 | 8 | $45 | $24 | $40.25 | $7.64 | 426.83% |
| 2022-05-17 | 8 | $46 | $24 | $40.375 | $7.64 | 428.47% |
| 2022-06-02 | 8 | $46 | $24 | $39.714 | $7.64 | 419.82% |
| 2022-06-08 | 8 | $46 | $24 | $39.571 | $7.64 | 417.95% |
| 2022-06-13 | 8 | $47 | $24 | $40.142 | $7.64 | 425.42% |
| 2022-07-26 | 9 | $47 | $25 | $40.625 | $7.64 | 431.74% |
| 2022-08-04 | 9 | $46 | $25 | $40.625 | $7.64 | 431.74% |
| 2022-08-08 | 9 | $45 | $25 | $39.375 | $7.64 | 415.38% |
| 2022-09-17 | 9 | $45 | $25 | $39.125 | $7.64 | 412.11% |
| 2022-10-17 | 9 | $45 | $24 | $38 | $7.64 | 397.38% |
| 2022-10-21 | 9 | $43 | $24 | $37.125 | $7.64 | 385.93% |
| 2022-10-28 | 9 | $44 | $24 | $37.25 | $7.64 | 387.57% |
| 2022-11-03 | 9 | $44 | $24 | $37.125 | $7.64 | 385.93% |
| 2022-12-05 | 10 | $44 | $24 | $36.111 | $7.64 | 372.66% |
| 2022-12-14 | 11 | $44 | $22 | $34.7 | $7.64 | 354.19% |
| 2023-01-26 | 10 | $44 | $22 | $34.666 | $7.64 | 353.74% |
| 2023-01-30 | 10 | $44 | $22 | $34.444 | $7.64 | 350.84% |
| 2023-02-01 | 10 | $44 | $22 | $34.555 | $7.64 | 352.29% |
| 2023-02-16 | 10 | $50 | $22 | $35.222 | $7.64 | 361.02% |
| 2023-02-21 | 11 | $52 | $22 | $37.6 | $7.64 | 392.15% |
| 2023-02-26 | 11 | $52 | $23 | $37.5 | $7.64 | 390.84% |
| 2023-02-28 | 10 | $52 | $23 | $37.3 | $7.64 | 388.22% |
| 2023-03-01 | 12 | $52 | $23 | $37.272 | $7.64 | 387.85% |
| 2023-03-14 | 12 | $52 | $23 | $37 | $7.64 | 384.29% |
| 2023-03-22 | 11 | $52 | $23 | $36.6 | $7.64 | 379.06% |
| 2023-04-10 | 11 | $52 | $23 | $36.9 | $7.64 | 382.98% |
| 2023-04-18 | 11 | $52 | $23 | $36.8 | $7.64 | 381.68% |
| 2023-05-02 | 11 | $43 | $23 | $32.7 | $7.64 | 328.01% |
| 2023-05-05 | 12 | $43 | $16 | $29.454 | $7.64 | 285.52% |
| 2023-05-23 | 13 | $42 | $16 | $28.666 | $7.64 | 275.21% |
| 2023-06-06 | 13 | $42 | $16 | $29.916 | $7.64 | 291.57% |
| 2023-07-10 | 14 | $42 | $16 | $29.307 | $7.64 | 283.6% |
| 2023-07-17 | 13 | $42 | $16 | $29.461 | $7.64 | 285.62% |
| 2023-07-18 | 14 | $41 | $16 | $28.923 | $7.64 | 278.57% |
| 2023-07-24 | 15 | $41 | $16 | $28.714 | $7.64 | 275.84% |
| 2023-08-04 | 15 | $41 | $17 | $28.785 | $7.64 | 276.77% |
| 2023-08-07 | 15 | $41 | $17 | $28.357 | $7.64 | 271.16% |
| 2023-08-13 | 15 | $41 | $17 | $28 | $7.64 | 266.49% |
| 2023-08-14 | 15 | $41 | $17 | $27.785 | $7.64 | 263.68% |
| 2023-08-30 | 15 | $41 | $17 | $27.571 | $7.64 | 260.88% |
| 2023-09-06 | 15 | $41 | $17 | $27.857 | $7.64 | 264.62% |
The Trend in the Analyst Price Target
Over the past 34 months, TVTX's average price target has gone down $4.03.
TVTX reports an average of 76.15% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-13 | 10 | 44 | 22 | 34.555 | 20.32 | 70.05% |
| 2023-01-26 | 10 | 44 | 22 | 34.666 | 21.83 | 58.8% |
| 2023-01-30 | 10 | 44 | 22 | 34.444 | 21.43 | 60.73% |
| 2023-06-06 | 14 | 42 | 16 | 29.916 | 19.34 | 54.68% |
| 2023-07-21 | 15 | 41 | 16 | 28.714 | 16.11 | 78.24% |
TVTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.27 | 13 | 0 | 2 | 0 | 0 | 15 |
The Trend in the Broker Recommendations
TVTX's average broker recommendation rating worsened by 0.1 over the prior 26 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, TRAVERE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 5701.9% of them.
- TRAVERE THERAPEUTICS INC's number of analysts covering the stock is higher than 5879.86% of stocks in the small market cap category.
- In the context of stocks in the small market cap category, TRAVERE THERAPEUTICS INC's average analyst price target is greater than 5026.95% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, TRAVERE THERAPEUTICS INC's variance in analysts' estimates is lower than -4200.4% of them.
In the Pharmaceutical Products industry, FBIO, ASMB, and HROW are the three stocks most similar to TRAVERE THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for TVTX? Use POWR Ratings for clearer insight into price direction.